US Bancorp DE Has $58,000 Position in agilon health, inc. (NYSE:AGL)

US Bancorp DE lifted its holdings in shares of agilon health, inc. (NYSE:AGL) by 93.7% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,425 shares of the company’s stock after purchasing an additional 1,173 shares during the quarter. US Bancorp DE’s holdings in agilon health were worth $58,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. Signaturefd LLC raised its position in shares of agilon health by 58.0% during the first quarter. Signaturefd LLC now owns 1,144 shares of the company’s stock worth $27,000 after purchasing an additional 420 shares during the period. Van ECK Associates Corp raised its position in shares of agilon health by 41.5% during the fourth quarter. Van ECK Associates Corp now owns 2,738 shares of the company’s stock worth $44,000 after purchasing an additional 803 shares during the period. Lazard Asset Management LLC acquired a new stake in shares of agilon health during the first quarter worth about $69,000. AdvisorNet Financial Inc raised its position in agilon health by 97.4% in the 1st quarter. AdvisorNet Financial Inc now owns 4,256 shares of the company’s stock valued at $101,000 after buying an additional 2,100 shares during the last quarter. Finally, SG Americas Securities LLC acquired a new stake in agilon health in the 1st quarter valued at approximately $110,000.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently issued reports on AGL shares. Stifel Nicolaus lifted their target price on agilon health from $29.00 to $32.00 in a research report on Wednesday, May 10th. Truist Financial dropped their target price on agilon health from $35.00 to $27.00 in a research report on Tuesday, June 20th. TD Cowen dropped their target price on agilon health from $29.00 to $25.00 and set an “outperform” rating on the stock in a research report on Tuesday, August 15th. The Goldman Sachs Group dropped their target price on agilon health from $29.00 to $25.00 and set a “buy” rating on the stock in a research report on Tuesday, August 15th. Finally, Evercore ISI initiated coverage on agilon health in a research report on Tuesday, June 13th. They set an “inline” rating and a $22.50 price target on the stock. Eight investment analysts have rated the stock with a buy rating, Based on data from MarketBeat, the company has an average rating of “Buy” and an average price target of $27.95.

Insider Transactions at agilon health

In other news, insider Benjamin Shaker sold 18,750 shares of agilon health stock in a transaction that occurred on Wednesday, July 12th. The stock was sold at an average price of $16.97, for a total transaction of $318,187.50. Following the completion of the transaction, the insider now directly owns 79,543 shares in the company, valued at approximately $1,349,844.71. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In the last three months, insiders sold 56,250 shares of company stock worth $1,008,750. 3.30% of the stock is owned by company insiders.

agilon health Stock Performance

Shares of NYSE AGL opened at $17.79 on Friday. The company has a current ratio of 1.50, a quick ratio of 1.50 and a debt-to-equity ratio of 0.04. agilon health, inc. has a 12 month low of $15.00 and a 12 month high of $29.44. The stock has a 50 day moving average of $17.87 and a 200-day moving average of $21.49. The company has a market capitalization of $7.21 billion, a P/E ratio of -84.71 and a beta of 0.98.

agilon health (NYSE:AGL) last issued its earnings results on Thursday, August 3rd. The company reported ($0.04) EPS for the quarter, missing the consensus estimate of ($0.01) by ($0.03). agilon health had a negative return on equity of 8.57% and a negative net margin of 2.39%. The business had revenue of $1.15 billion for the quarter, compared to the consensus estimate of $1.11 billion. As a group, equities research analysts predict that agilon health, inc. will post -0.14 EPS for the current year.

agilon health Company Profile

agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2022, it served approximately 269,500 medicare advantage members and 89,000 Medicare fee-for-service beneficiaries. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.